Safety of Enoxaparin during Pregnancy

Meital Shlomo, Rafael Gorodischer, Gideon Koren, Arnon Wiznitzer, Ilan Matok, Amalia Levy

Research output: Contribution to journalMeeting Abstractpeer-review


As pregnancy is a hypercoaguable state, the risk for thromboembolic event rises. With thromboembolism being the leading cause of death among pregnant women in developed countries, anticoagulation therapy is needed more commonly. Warfarin teratogenicity and heparin's safety profile have placed enoxaparin as the drug of choice for anticoagulation therapy during pregnancy. While several studies investigated enoxaparin effectiveness during gestation, its fetal safety has been only sparsely studied. The aim of this study was to evaluate fetal safety after enoxaparin exposure during pregnancy.
Original languageEnglish
Pages (from-to)526-527
Number of pages2
JournalBirth Defects Research Part A Clinical and Molecular Teratology
StatePublished - 1 Jul 2014


Dive into the research topics of 'Safety of Enoxaparin during Pregnancy'. Together they form a unique fingerprint.

Cite this